Dr. Simon Dujardin
Massachusetts General Hospital & Harvard Medical School
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s Disease.
Friday 12 June 2020
3 PM – 4 PM
Zoom webinar
Prof. Mark Albers
Massachusetts General Hospital & Harvard Medical School
A common mechanism for inflammatory neuronal death in Alzheimer’s Disease and ALS: from bench to basket clinical trial.
Thursday 12 December 2019
12 PM – 1 PM
Foyer Meeting Room, Gower Street, Cruciform Building
Dr. Neil Oxtoby
UCL Department of Computer Science
An introduction to data-driven computational modelling of neurodegenerative disease progression.
Thursday 31 October 2019
12 PM – 1 PM
Foyer Meeting Room 2, Gower Street, Cruciform Building
Dr. Ulf Neumann
Novartis Institutes of BioMedical Research, Basel, Switzerland
BACE inhibitor CNP520 for prevention of Alzheimer’s disease.
Wednesday 18 September 2019
3 PM – 4.30 PM
Boardroom, Gower Street, Cruciform Building
Dr. Hongbo Jia
Suzhou Institute of Biomedical Engineering and Technology,
Chinese Academy of Sciences
‘Holistic Bursting’: A logic of learning-transformed single-cell firing mode.
Friday 13 September 2019
12 PM – 13P M
Boardroom, Gower Street, Cruciform Building
Busche lab - UKDRI at UCL 